ProCE Banner Activity

Poorer Outcomes With Rituximab + Chemo in Heavier Patients, Older Men With Follicular Lymphoma

Slideset Download
Conference Coverage
Retrospective analysis suggests that subsets of patients with FL may receive suboptimal doses of rituximab.

Released: June 05, 2015

Expiration: June 03, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation